Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process
Published Date
Copyright 2005
DOI 10.2202/1558-9544.1013
You may be able to download this chapter for free via the Document Object Identifier.
-
Copy CitationErnst R. Berndt, Adrian H. B. Gottschalk, Tomas Philipson, and Matthew W. Strobeck, Frontiers in Health Policy Research, Volume 8 (Berkeley Electronic Press , 2005), chap. 1, https://www.nber.org/books-and-chapters/frontiers-health-policy-research-volume-8/assessing-impacts-prescription-drug-user-fee-acts-pdufa-fda-approval-process.
Related
Published From Paper
-
Working Paper
Congress enacted and renewed the Prescription Drug User Fee Acts (PDUFA) in 1992, and renewed it in 1997 and 2002,...
More from the NBER
In addition to working papers, the NBER disseminates affiliates’ latest findings through a range of free periodicals — the NBER Reporter, the NBER Digest, the Bulletin on Health, and the Bulletin on Entrepreneurship — as well as online conference reports, video lectures, and interviews.
N. Gregory Mankiw, Robert M. Beren Professor of Economics at Harvard University, presented the 2025 Martin Feldstein...
SlidesBackground materials on mediationImai, Kosuke, Dustin Tingley, and Teppei Yamamoto. (2013). “Experimental Designs...
Supported by the Alfred P. Sloan Foundation grant #G-2023-19633, the Lynde and Harry Bradley Foundation grant #20251294...